An interventional study of walking exercise in Celiac Disease, Metabolic Syndrome and Non Alcoholic Fatty Liver, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to female participants aged 13 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-09-22.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
metabolic syndrome and fatty liver is common in adolescents with celiac diseases. exercise may control these cardiovascular risk factors
forty metabolic syndrome and fatty liver female adolescents with celiac diseases will assigned to exercise group or control group. the group will contain twenty patients. control group will be wait list. exercise group will perform 40 minutes of walking on a treadmill three times weekly for three months.
352 studies on the registry are indexed under Celiac Disease; 77 are open to participants now.
This study's planned enrollment of 40 is below the median of 50 across 214 interventional studies indexed under Celiac Disease.
Browse Celiac Disease studies →Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
twenty metabolic syndrome and fatty liver female adolescents with celiac diseases will will perform 40 minutes of walking on a treadmill three times weekly for three months.
Behavioral: walking exercise
twenty metabolic syndrome and fatty liver female adolescents with celiac diseases will be wait list for three months.
twenty metabolic syndrome and fatty liver female adolescents with celiac diseases will will perform 40 minutes of walking on a treadmill three times weekly for three months.
alanine transamianse
It will be asssessed in plasma
Time frame: It will be measured after 12 weeks
Asparate tranamianse
it will be assessed in plasma
Time frame: It will be measured after 12 weeks
gamma glutamyl transferase
it will be assessed in plasma
Time frame: it will be measured after 12 weeks
alkaline phosphatase
it will be assessed in plasma
Time frame: it will be measured after 12 weeks
Body mass index
it wil be measured with empty stomach and bladder
Time frame: it will be assessed after 12 weeks
wasit circumference
it will be assessed at the level of umbilicus
Time frame: it will be assessed after 12 weeks
systolic blood pressure
it will be assessed at level of brachial artery
Time frame: it will be assessed after 12 weeks
diastolic blood pressure
it will be assessed at level of brachial artery
Time frame: it will be assessed after 12 weeks
blood glucose
it will be measured in fasting status in blood
Time frame: it will be assessed after 12 weeks
high density lipoproteins
it will be assessed in plasma
Time frame: it will be assessed after 12 weeks
triglycerides
it will be assessed in plasma
Time frame: it will be assessed after 12 weeks
Started Aug 2026 (actual). Primary completion is estimated for Dec 2026, 4 months after the start.
Of 82 non-industry interventional studies with no phase under Celiac Disease, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 60. This study's planned 4 months is below that.
Counting every sponsor, half of 87 studies reached it within 27 months; a quarter within 12 and three quarters within 56.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.